Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response

Stem Cell Reports

Volumn 4, Issue 2, 2015, Pages 239-254

  Chapellier, Marion ^a,b,c,d   Bachelard Cascales, Elodie ^e   Schmidt, Xenia ^a,b,c,d   Clément, Flora ^a,b,c,d   Treilleux, Isabelle ^a,b,c,d,f   Delay, Emmanuel ^a,b,c,d,f   Jammot, Alexandre ^a,b,c,d   Ménétrier Caux, Christine ^a,b,c,d,f   Pochon, Gaëtan ^a,b,c,d   Besançon, Roger ^a,b,c,d   Voeltzel, Thibault ^a,b,c,d   Caron De Fromentel, Claude ^a,b,c,d   Caux, Christophe ^a,b,c,d,f   Blay, Jean Yves ^a,b,c,d,f   Iggo, Richard ^e   Maguer Satta, Véronique ^a,b,c,d  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Virus and Microenvironment ^*  (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CARCINOGEN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1;

ARTICLE; BREAST EPITHELIUM CELL; BREAST TUMOR; CELL MATURATION; CELL TRANSFORMATION; HUMAN; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MYOEPITHELIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL NICHE; TUMOR MICROENVIRONMENT; CANCER STEM CELL; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CARCINOGENS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

EID: 84922565676     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.12.007     Document Type: Article

References (45)

1. E.L. Alarmo, H. Huhtala, T. Korhonen, L. Pylkkanen, K. Holli, T. Kuukasjarvi, S. Parkkila, and A. Kallioniemi Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development Mod. Pathol. 26 2013 10 21
2. E. Bachelard-Cascales, M. Chapellier, E. Delay, G. Pochon, T. Voeltzel, A. Puisieux, C. Caron de Fromentel, and V. Maguer-Satta The CD10 enzyme is a key player to identify and regulate human mammary stem cells Stem Cells 28 2010 1081 1088
3. E. Bachelard-Cascales, M. Chapellier, E. Delay, and V. Maguer-Satta A protocol to quantify mammary early common progenitors from long-term mammosphere culture Curr. Protoc. Stem Cell Biol. Chapter 1 2012 Unit 1E.7, 1E.7.1-1E.7.6
4. A.L. Balboni, J.A. Hutchinson, A.J. DeCastro, P. Cherukuri, K. Liby, M.B. Sporn, G.N. Schwartz, W.A. Wells, L.F. Sempere, P.B. Yu, and J. DiRenzo ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells Cancer Res. 73 2013 1020 1030
5. N. Ben-Jonathan, E.R. Hugo, and T.D. Brandebourg Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome Mol. Cell. Endocrinol. 304 2009 49 54
6. S.M. Bokobza, L. Ye, H.E. Kynaston, R.E. Mansel, and W.G. Jiang Reduced expression of BMPR-IB correlates with poor prognosis and increased proliferation of breast cancer cells Cancer Genomics Proteomics 6 2009 101 108
7. J.H. Clement, M. Raida, J. Sänger, R. Bicknell, J. Liu, A. Naumann, A. Geyer, A. Waldau, P. Hortschansky, and A. Schmidt Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells Int. J. Oncol. 27 2005 401 407
8. P. Cottu, E. Marangoni, F. Assayag, P. de Cremoux, A. Vincent-Salomon, Ch. Guyader, L. de Plater, C. Elbaz, N. Karboul, and J.J. Fontaine Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts Breast Cancer Res. Treat. 133 2012 595 606
9. S.R. Davies, G. Watkins, A. Douglas-Jones, R.E. Mansel, and W.G. Jiang Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance J. Exp. Ther. Oncol. 7 2008 327 338
10. J. Debnath, S.K. Muthuswamy, and J.S. Brugge Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 2003 256 268
11. J. Faget, C. Biota, T. Bachelot, M. Gobert, I. Treilleux, N. Goutagny, I. Durand, S. Léon-Goddard, J.Y. Blay, C. Caux, and C. Ménétrier-Caux Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells Cancer Res. 71 2011 6143 6152
12. P. Farmer, H. Bonnefoi, V. Becette, M. Tubiana-Hulin, P. Fumoleau, D. Larsimont, G. Macgrogan, J. Bergh, D. Cameron, and D. Goldstein Identification of molecular apocrine breast tumours by microarray analysis Oncogene 24 2005 4660 4671
13. G. Finkenzeller, S. Hager, and G.B. Stark Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells Microvasc. Res. 84 2012 81 85
14. C.L. Forsman, B.C. Ng, R.K. Heinze, C. Kuo, C. Sergi, R. Gopalakrishnan, D. Yee, D. Graf, K.L. Schwertfeger, and A. Petryk BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization Dev. Biol. 373 2013 95 106
15. J.M. Gerber, J.L. Gucwa, D. Esopi, M. Gurel, M.C. Haffner, M. Vala, W.G. Nelson, R.J. Jones, and S. Yegnasubramanian Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations Oncotarget 4 2013 715 728
16. M.W. Helms, J. Packeisen, C. August, B. Schittek, W. Boecker, B.H. Brandt, and H. Buerger First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer J. Pathol. 206 2005 366 376
17. S.L. Hyzy, R. Olivares-Navarrete, D.L. Hutton, C. Tan, B.D. Boyan, and Z. Schwartz Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2 Acta Biomater. 9 2013 5821 5829
18. D. Iliopoulos, H.A. Hirsch, G. Wang, and K. Struhl Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc. Natl. Acad. Sci. USA 108 2011 1397 1402
19. S. Jeanpierre, F.E. Nicolini, B. Kaniewski, C. Dumontet, R. Rimokh, A. Puisieux, and V. Maguer-Satta BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling Blood 112 2008 3154 3163
20. M. Kadota, H.H. Yang, B. Gomez, M. Sato, R.J. Clifford, D. Meerzaman, B.K. Dunn, L.M. Wakefield, and M.P. Lee Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines PLoS ONE 5 2010 e9201
21. N. Kannan, N. Huda, L. Tu, R. Droumeva, G. Aubert, E. Chavez, R.R. Brinkman, P. Lansdorp, J. Emerman, and S. Abe The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunction Stem Cell Rep. 1 2013 28 37
22. Y. Katsuno, A. Hanyu, H. Kanda, Y. Ishikawa, F. Akiyama, T. Iwase, E. Ogata, S. Ehata, K. Miyazono, and T. Imamura Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway Oncogene 27 2008 6322 6333
23. P.J. Keller, L.M. Arendt, A. Skibinski, T. Logvinenko, I. Klebba, S. Dong, A.E. Smith, A. Prat, C.M. Perou, and H. Gilmore Defining the cellular precursors to human breast cancer Proc. Natl. Acad. Sci. USA 109 2012 2772 2777
24. H. Kouros-Mehr, E.M. Slorach, M.D. Sternlicht, and Z. Werb GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 2006 1041 1055
25. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
26. B. Laperrousaz, S. Jeanpierre, K. Sagorny, T. Voeltzel, S. Ramas, B. Kaniewski, M. Ffrench, S. Salesse, F.E. Nicolini, and V. Maguer-Satta Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression Blood 122 2013 3767 3777
27. H.J. Li, F. Reinhardt, H.R. Herschman, and R.A. Weinberg Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling Cancer Discov. 2 2012 840 855
28. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen kConFab Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat. Med. 15 2009 907 913
29. V. Maguer-Satta The stem cell niche: the black master of cancer S. Stanley, Cancer Stem Cells 2011 Intech 215 240
30. K. McLean, Y. Gong, Y. Choi, N. Deng, K. Yang, S. Bai, L. Cabrera, E. Keller, L. McCauley, K.R. Cho, and R.J. Buckanovich Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production J. Clin. Invest. 121 2011 3206 3219
31. G. Molyneux, F.C. Geyer, F.A. Magnay, A. McCarthy, H. Kendrick, R. Natrajan, A. Mackay, A. Grigoriadis, A. Tutt, and A. Ashworth BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells Cell Stem Cell 7 2010 403 417
32. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, and F. Tong A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
33. M.M. Pires, B.D. Hopkins, L.H. Saal, and R.E. Parsons Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells Cancer Biol. Ther. 14 2013 246 253
34. M. Raida, J.H. Clement, R.D. Leek, K. Ameri, R. Bicknell, D. Niederwieser, and A.L. Harris Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis J. Cancer Res. Clin. Oncol. 131 2005 741 750
35. M. Rendl, L. Polak, and E. Fuchs BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties Genes Dev. 22 2008 543 557
36. A. Rundle, D. Tang, H. Hibshoosh, A. Estabrook, F. Schnabel, W. Cao, S. Grumet, and F.P. Perera The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer Carcinogenesis 21 2000 1281 1289
37. K. Sagorny, M. Chapellier, B. Laperrousaz, and V. Maguer-Satta [BMP and cancer: the Yin and Yang of stem cells] Med. Sci. (Paris) 28 2012 416 422
38. J. Stingl, A. Raouf, J.T. Emerman, and C.J. Eaves Epithelial progenitors in the normal human mammary gland J. Mammary Gland Biol. Neoplasia 10 2005 49 59
39. Y. Sun, J. Campisi, C. Higano, T.M. Beer, P. Porter, I. Coleman, L. True, and P.S. Nelson Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B Nat. Med. 18 2012 1359 1368
40. J.P. Thawani, A.C. Wang, K.D. Than, C.Y. Lin, F. La Marca, and P. Park Bone morphogenetic proteins and cancer: review of the literature Neurosurgery 66 2010 233 246 discussion 246
41. S.C. Van Huffel, J.M. Tham, X. Zhang, K. Lim, C. Yang, Y. Tan, F. Ong, I. Lee, and W. Hong Systematic analysis of secreted proteins reveals synergism between IL6 and other proteins in soft agar growth of MCF10A cells Cell Biosci 1 2011 13
42. D.B. Vendramini-Costa, and J.E. Carvalho Molecular link mechanisms between inflammation and cancer Curr. Pharm. Des. 18 2012 3831 3852
43. K. Weber Lozada, and R.A. Keri Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer Biol. Reprod. 85 2011 490 497
44. J.N. Zara, R.K. Siu, X. Zhang, J. Shen, R. Ngo, M. Lee, W. Li, M. Chiang, J. Chung, and J. Kwak High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo Tissue Eng. Part A 17 2011 1389 1399
45. J. Zhang, C. Niu, L. Ye, H. Huang, X. He, W.G. Tong, J. Ross, J. Haug, T. Johnson, and J.Q. Feng Identification of the haematopoietic stem cell niche and control of the niche size Nature 425 2003 836 841